Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 4

1(16.7%)

Early Phase 1

1(16.7%)

Phase 2

1(16.7%)

6Total

N/A(3)

Phase 4(1)

Early Phase 1(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT07372027Not ApplicableRecruiting

Single-Needle Distal Return for Long-Term Arteriovenous Fistula Care

Role: lead

NCT07335471Not ApplicableCompleted

Prevention and Management of Cardiovascular and Cerebrovascular Complications in Maintenance Hemodialysis (MHD) Patients

Role: lead

NCT07128212Not ApplicableCompleted

Atorvastatin Mitigates WMH-Related Cognitive Impairment by Reducing VCAM-1

Role: lead

NCT06898723Phase 4Recruiting

The Preventive Effect of Shenfu Injection on Myocardial Dysfunction in Sepsis

Role: collaborator

NCT06238024Phase 2Completed

Effect of Interleukin-6 Receptor Inhibition in Patients With Ischemic Stroke Undergoing Endovascular Treatment

Role: lead

NCT06539260Early Phase 1Completed

Clinical Relationship Between Vitamin D-mediated Th17 and Treg Cells and Parkinson's Disease

Role: lead

All 6 trials loaded